CLINICAL TRIAL: PACTG 1058:INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL D
CLINICAL TRIAL: PACTG 1058:INTENSIVE PHARMACOKINETIC STUDIES OF ANTIRETROVIRAL D
批准号:
7951157
负责人:
DOUGLAS WATSON
金额:
$0.53万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-01 至 2010-06-30
关键词:
AdolescentAdultAffectAnti-Retroviral AgentsChildClinical ResearchClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDrug KineticsDrug usageFundingGrantHIVHIV InfectionsHourInstitutionPharmaceutical PreparationsResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthinterest
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Treating HIV infection requires combinations of at least 3, and often many more drugs. Several of the drugs used to treat HIV affect how the body eliminates other HIV drugs. Many of these interactions have been studied in adults, but far less is known about their use in children and adolescents. This study will look at the level of HIV drugs over a 12-hour period in children and adolescents who have been prescribed one of three combinations of HIV drugs of interest. This information will help doctors decide how much drug they should prescribe.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PEDIATRIC HIV/AIDS COHORT STUDIES: ADOLESCENT MASTER PROTOCOL (AMP)
-
批准号:7951181
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:DOUGLAS WATSON
-
依托单位:
PHASE I/II, OPEN LABEL, PHARMACOKINETIC AND SAFETY STUDY OF A NOVEL PROTEASE
-
批准号:7608133
-
项目类别:
-
资助金额:$0.42万
-
财政年份:2007
-
负责人:DOUGLAS WATSON
-
依托单位:
海外基金